CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • How Immunotherapy for Esophageal Cancer is Making an Impact

    Dr. Deirdre Cohen discusses recent advances in immunotherapy for esophageal cancer, including biomarkers, checkpoint inhibitors, cell-based therapies,…

    April 27, 2020| Arthur N. Brodsky, PhD
  • Vaccine-Chemo Combo Shows Promise in Treating Advanced, HPV-Associated Cervical Cancer

    Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with…

    March 27, 2020| Arthur N. Brodsky, PhD
  • COVID-19 and the Immune System: How Cancer Research Can Help Rein in the Novel Coronavirus Pandemic

    Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.

    March 25, 2020| Arthur N. Brodsky, PhD
  • International HPV Awareness Day and the Importance of Immunotherapy

    Immunotherapy is crucial to efforts to prevent HPV infection and treat patients with HPV-associated cancers.

    March 4, 2020| Arthur N. Brodsky, PhD
  • Meet Dr. Andrea Schietinger, One of Our New Lloyd J. Old STAR Scientists

    Zooming into the tumor and following cell populations over time throughout tumor development or therapeutic response with…

    February 17, 2020| Arthur N. Brodsky, PhD
  • Love in the Lab: Valentine’s Day with Scientific Couples

    Shining a light on the softer side of science to show that science and love can be,…

    February 13, 2020| Arthur N. Brodsky, PhD
  • Cancer Immunotherapy in 2020 and Beyond

    Dr. Padmanee Sharma discusses progress in hard-to-treat cancers, biomarkers, the microbiome, new treatment approaches, emerging collaboration models,…

    January 29, 2020| Arthur N. Brodsky, PhD
  • Meet Dr. Gregory F. Sonnenberg, One of Our New Lloyd J. Old STAR Scientists

    How the microbiome influences the fight against cancer and what Dr. Sonnenberg hopes to accomplish during the next five…

    January 6, 2020| Arthur N. Brodsky, PhD
  • Meet Dr. Yvonne Chen, One of Our New Lloyd J. Old STAR Scientists

    We spoke with Dr. Yvonne Chen to learn more about her work in chemical engineering to fight…

    December 11, 2019| Arthur N. Brodsky, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute